FENC Earnings

Quarterly EPS
$-0.21
Q3 2024
$-0.07
Q4 2024
$-0.04
Q1 2025
$-0.11
Q2 2025
$-0.02
Q3 2025
$-0.15
Q4 2025
$0.01
Q1 2026
$0.06
Q2 2026
Latest Revenue17.9M
Latest Net Income2.0M
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026$0.0617.9M2.0M+85.2%+154.5%
Q1 2026$0.0115.1M201.0K+72.6%+125.0%
Q4 2025-$0.1513.8M-4787000+73.8%-114.3%
Q3 2025-$0.0212.5M-638000+78.7%+90.5%
Q2 2025-$0.119.7M-3152000+32.9%+45.0%
Q1 2025-$0.048.8M-1165000-65.5%-108.5%
Q4 2024-$0.077.9M-1985000-18.6%+30.0%
Q3 2024-$0.217.0M-5735000+7.0%-200.0%
Q2 2024-$0.207.3M-5553000
Q1 2024$0.4725.4M12.8M
Q4 2023-$0.109.7M-2682000
Q3 2023-$0.076.5M-1867000
Fennec Pharmaceuticals (FENC) — Earnings